FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:516 August 17, 2000 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Jack L. Leahy, Nathaniel G. Clark, and William T. Cefalu. 761 pp. New York, Marcel Dekker, 2000. $99.75. ISBN 0-8247-8857-5.

More than 150 million people in the world have diabetes, the prevalence of which is increasing so rapidly that the management of diabetes is a priority in all branches of medicine. The new therapies and rapidly evolving evidence are making us all reevaluate our practice. We can no longer be one-dimensional "sugar doctors" but, instead, must address the three dimensions of cardiovascular risk prevention: glycemia, lipid levels, and blood pressure.

In addition to knowing the evidence, we all need practical advice. The detached reviewer can point to the inadequate number of randomized controlled studies of the treatment of diabetic ketoacidosis, . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.